Vanda Pharmaceuticals Inc.
SEC CIK 1347178 · VNDA · last insider filing 2026-06-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dugan Richard W | Director | filed 2006 - 2026 |
| Chrousos Phaedra | Director | filed 2019 - 2026 |
| Ward Anne Sempowski | Director | filed 2019 - 2026 |
| Mitchell Stephen Ray | Director | filed 2020 - 2026 |
| Honore Tage | Director | filed 2023 - 2026 |
| Duncan Charles Cliff | Director | filed 2026 - 2026 |
| Polymeropoulos Mihael Hristos | Director · President and CEO | filed 2006 - 2026 |
| Watkins Thomas | Director | filed 2006 - 2022 |
| Cola Michael F | Director | filed 2012 - 2019 |
| Milano Vincent | Director | filed 2010 - 2018 |
| Bate Kenneth | Director | filed 2015 - 2017 |
| Pien Howard H | Director | filed 2007 - 2015 |
| Galson Steven K | Director | filed 2010 - 2014 |
| Karabelas Argeris N | Director · Chairman of the Board | filed 2006 - 2011 |
| Halak Brian K | Director | filed 2006 - 2010 |
| Ramsay David Russ | Director | filed 2006 - 2010 |
| Tananbaum James B | Director | filed 2006 - 2007 |
| Hockmeyer Wayne T | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mcguire Daniel Patrick | SVP, GC and Secretary | filed 2026 - 2026 |
| Howell Scott Laverne | VP and Chief People Officer | filed 2026 - 2026 |
| Polymeropoulos Christos Vasilios Mihael | Senior VP, Medical Director | filed 2026 - 2026 |
| Birznieks Gunther | SVP, Business Development | filed 2017 - 2026 |
| Williams Timothy | SVP & General Counsel | filed 2018 - 2026 |
| Wijkstrom Joakim | SVP, Chief Marketing Officer | filed 2019 - 2026 |
| Moran Kevin Patrick | VP, Acting CFO & Treasurer | filed 2020 - 2026 |
| Jones Aranthan II | Chief Corp. Affairs Officer | filed 2019 - 2021 |
| Kelly James Patrick | SVP, CFO, Treasurer & Secretar | filed 2010 - 2020 |
| Reverberi Gian Piero | SVP, General Manager Europe | filed 2015 - 2020 |
| Gulino Richard L. | SVP, General Counsel & Sec. | filed 2015 - 2018 |
| Baroldi Paolo | SVP & Chief Medical Officer | filed 2006 - 2017 |
| Gibbs Thomas Edward | SVP, Chief Commercial Officer | filed 2015 - 2015 |
| Repella Robert | SVP & Chief Commercial Officer | filed 2011 - 2013 |
| Feeney John Joseph | SVP & Chief Medical Officer | filed 2009 - 2012 |
| Clark William D | Sr. VP, Chief Business Officer | filed 2006 - 2010 |
| Irish Stephanie Rast | Sr. VP, CFO, Treasurer | filed 2009 - 2010 |
| Shallcross Steven A | Sr. VP, CFO, Treasurer | filed 2006 - 2008 |
| Gianchetti Albert W. | Sr.VP,Chief Commercial Officer | filed 2007 - 2008 |
| Phadke Deepak Shripad | Vice President Manufacturing | filed 2006 - 2006 |
| Copmann Thomas Lyle | VP of Regulatory Affairs | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.